European Hematology Association

European Hematology Association is a professional organization that aims to promote Hematology and Oncology research, education, and clinical practice in Europe. The association was founded in 1992 by a group of prominent Hematologists, including Jan van Rood and Daniel Catovsky, with the goal of advancing the field of Hematology and improving patient care. The association is headquartered in The Hague, Netherlands, and has established partnerships with other organizations, such as the American Society of Hematology and the International Society of Hematology. The association's activities are supported by its members, who include Hematologists, Oncologists, and other healthcare professionals from across Europe, including United Kingdom, Germany, France, and Italy.

● History

The European Hematology Association was established in 1992, with the first Congress held in London, United Kingdom, in 1994. The association's early years were marked by significant growth, with the establishment of the European Hematology Association Congress as an annual event, attracting Hematologists and Oncologists from across Europe, including Spain, Sweden, and Poland. The association has also established relationships with other organizations, such as the European Society for Medical Oncology and the European Association for Cancer Research, to promote collaboration and advance the field of Hematology and Oncology. The association's history is closely tied to the development of Hematology and Oncology in Europe, with notable contributions from researchers and clinicians, including Alexander H. Fischer, Andreas Engert, and Robin Foa.

● Organization

The European Hematology Association is governed by a Board of Directors, which includes representatives from various European countries, such as Germany, France, and Italy. The association's President serves a two-year term, with past presidents including Jan van Rood, Daniel Catovsky, and Andreas Engert. The association has established several committees, including the Scientific Committee and the Education Committee, to oversee its activities and promote the development of Hematology and Oncology in Europe. The association also collaborates with other organizations, such as the European Medicines Agency and the European Commission, to advance the field and improve patient care.

● Membership

Membership in the European Hematology Association is open to Hematologists, Oncologists, and other healthcare professionals from across Europe, including United Kingdom, Germany, France, and Italy. The association has a diverse membership, with members from various European countries, including Spain, Sweden, and Poland. Members have access to a range of benefits, including reduced registration fees for the European Hematology Association Congress, access to the association's Publications, and opportunities for networking and collaboration with other professionals in the field. The association also offers membership to Students and Residents in Hematology and Oncology programs, such as those at University of Oxford, University of Cambridge, and Karolinska Institutet.

● Congress

The European Hematology Association Congress is an annual event that brings together Hematologists and Oncologists from across Europe to share the latest research and advances in the field. The congress features a range of Symposia, Workshops, and Oral Presentations, as well as a Poster Session and an Exhibition. The congress is attended by professionals from across Europe, including United Kingdom, Germany, France, and Italy, as well as from other regions, such as United States, Canada, and Australia. The congress has been held in various locations across Europe, including London, Berlin, Paris, and Amsterdam, and has become a premier event in the field of Hematology and Oncology.

● Publications

The European Hematology Association publishes several Journals, including HemaSphere and European Hematology Association Library, which feature original research, reviews, and commentary on the latest developments in Hematology and Oncology. The association also publishes a range of Guidelines and Recommendations for the diagnosis and treatment of Hematological disorders, such as Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia. The association's publications are widely read and respected, and are available to members and non-members alike, including researchers and clinicians at institutions such as National Institutes of Health, Cancer Research UK, and German Cancer Research Center.

● Advocacy

The European Hematology Association is committed to advocating for the interests of Hematologists and Oncologists across Europe, as well as for the needs of patients with Hematological disorders. The association works closely with other organizations, such as the European Cancer Patient Coalition and the European Patients' Forum, to promote patient-centered care and to advocate for increased funding for Hematology and Oncology research. The association also engages with policymakers and regulatory agencies, such as the European Commission and the European Medicines Agency, to ensure that the needs of patients and professionals in the field are represented and addressed. The association's advocacy efforts are supported by its members, who include Hematologists and Oncologists from across Europe, including United Kingdom, Germany, France, and Italy.

Category:Medical and health organizations